DENVER, Colo., Dec 02, 2025 (247marketnews.com)- Markets open today with a mix of AI-driven exuberance, biotech anticipation, and selective small-cap momentum as investors digest a heavy slate of company-specific catalysts heading into the first full week of December.
Biotech Watch: Jasper Therapeutics Sets the Tone (NASDAQ:JSPR)
Jasper Therapeutics (JSPR) is firmly on traders’ radar this morning as the company prepares for its December 2 investor webinar at 8:00 a.m. ET, where it will address anomalous BEACON CSU study results reported in July and unveil preliminary ETESIAN asthma data.
The session will feature Jasper management and Dr. Martin Metz, lead EU investigator for BEACON, followed by a live Q&A. With briquilimab positioned as a potentially disruptive antibody therapy in mast-cell–driven diseases, investors are bracing for data-driven volatility. Slides and a replay will post to Jasper’s IR site following the event.
AI Hardware Momentum: Credo Technology Group Delivers a Breakout Quarter (NASDAQ:CRDO)
Credo Technology (CRDO) reported what CEO Bill Brennan called the strongest quarterly results in the company’s history, reflecting the global escalation of AI infrastructure build-outs.
Q2 FY26 highlights:
- Revenue: $268M, up 20% QoQ and 272% YoY
- GAAP net income: $82.6M
- Non-GAAP net income: $127.8M
- GAAP gross margin: 67.5%
- Ending cash: $813.6M
Credo’s positioning across AEC, IC, ZeroFlap optics, ALCs, and the new OmniConnect gearbox products underpins its bullish Q3 FY26 revenue outlook of $335M–$345M.
Kraig Biocraft Laboratories Expands (OTCQB:KBLB)
KBLB continues to expand as the company accelerates hiring across Southeast Asia to scale industrial spider silk production, long a high-risk, high-reward materials-science frontier.
Training under renowned sericulture expert Dr. Nirmal Kumar signals meaningful progress toward industrial throughput. Market watchers anticipate production milestone updates in early 2026.
Consumer Alt-Protein Quick Hit: Beyond Meat (NASDAQ:BYND)
The stock could repeat its late-October volatility spike, so look for scalping opportunities.
Corporate Action: Fitell Corporation Launches $3M Buyback (NASDAQ:FTEL)
Fitell Corporation (FTEL) announced a $3M, 24-month share repurchase program, yesterdayfunded with existing cash and future operating flows. The program is flexible, allowing open-market and block transactions under Rule 10b-18.
CEO Sam Lu framed the move as a response to improving balance-sheet strength and undervalued shares following FY25 results. Fitell continues to invest in e-commerce, AI-enabled robotics, and digital asset treasury strategies.
Market read: Microcap buybacks seldom move shares long-term, but FTEL may see short-term upside from liquidity tightening and sentiment improvement.
Software & AI Data Infrastructure: MongoDB Posts Another Strong Quarter (NASDAQ:MDB)
MongoDB (MDB) delivered a highly watched Q3 FY26 report with strong results and guidance:
- Total revenue: $628.3M, up 19% YoY
- Atlas: 30% YoY growth; 75% of total revenue
- Non-GAAP operating income: $123.1M
- Non-GAAP net income: $114.5M ($1.32/share)
- Free cash flow: $140.1M
The company added 2,600 new customers, surpassing 62,500 total, and highlighted expanding adoption across mission-critical workloads as enterprises accelerate their shift toward AI-ready data architectures.
MongoDB also marked several strategic milestones:
- Appointment of CJ Desai as new CEO
- Recognition as a Leader in the 2025 Gartner CDBMS Magic Quadrant
- Expansion of search and vector search to Community and Enterprise Server editions
- Deepened integrations with Microsoft, earning 2025 U.S. Partner of the Year
For more information about Kraig Labs’ spider silk technology and partnership opportunities, visit www.kraiglabs.com
Please click here to read the full Kraig Labs analyst report on 247marketnews.com.
For more information, please visit: www.kraiglabs.com
Contact [email protected] for Analyst Report coverage and other investor/public relations services.
PAID EDITORIAL DISCLOSURE: This is a paid editorial communication intended for informational purposes only. 247 is a third-party media provider and has been compensated for providing ongoing KBLB market outreach and other services. This press release may include technical analysis and should not be construed as financial or investment advice. Trading stocks involves risks, and readers should consult with their financial advisor before making investment decisions. Please review 247’s Full Disclaimer https://www.247marketnews.com/disclaimer/. Please go to https://247marketnews.com/kblb-disclosure/ for further KBLB and 247marketnews.com disclosure information.
Cautionary Note Regarding Forward-Looking Statements
This press release contains forward-looking statements that are subject to various risks and uncertainties. Such statements include statements regarding the Company’s ability to grow its business and other statements that are not historical facts, including statements which may be accompanied by the words “intends,” “may,” “will,” “plans,” “expects,” “anticipates,” “projects,” “predicts,” “estimates,” “aims,” “believes,” “hopes,” “potential” or similar words. Actual results could differ materially from those described in these forward-looking statements due to a number of factors, including without limitation, the Company’s ability to continue as a going concern, general economic conditions, and other risk factors detailed in the Company’s filings with the SEC. The forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake any responsibility to update such forward-looking statements except in accordance with applicable law.
The post AI INFRASTRUCTURE SURGE MEETS BIOTECH BUZZ appeared first on 24/7 MarketNews.